KR20210040899A - Method for preparing Citrus peel extract containing increased content of flavonoid - Google Patents
Method for preparing Citrus peel extract containing increased content of flavonoid Download PDFInfo
- Publication number
- KR20210040899A KR20210040899A KR1020210041320A KR20210041320A KR20210040899A KR 20210040899 A KR20210040899 A KR 20210040899A KR 1020210041320 A KR1020210041320 A KR 1020210041320A KR 20210041320 A KR20210041320 A KR 20210041320A KR 20210040899 A KR20210040899 A KR 20210040899A
- Authority
- KR
- South Korea
- Prior art keywords
- content
- citrus
- increased
- citrus peel
- temperature
- Prior art date
Links
- 235000020971 citrus fruits Nutrition 0.000 title claims abstract description 104
- 241000207199 Citrus Species 0.000 title claims abstract description 76
- 230000001965 increasing effect Effects 0.000 title claims abstract description 74
- 239000000284 extract Substances 0.000 title claims abstract description 51
- 229930003935 flavonoid Natural products 0.000 title claims abstract description 50
- 235000017173 flavonoids Nutrition 0.000 title claims abstract description 50
- 150000002215 flavonoids Chemical class 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims description 11
- LKMNXYDUQXAUCZ-UHFFFAOYSA-N sinensetin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C=C2O1 LKMNXYDUQXAUCZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 claims abstract description 42
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 34
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 26
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims abstract description 26
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 26
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims abstract description 26
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims abstract description 26
- 229940025878 hesperidin Drugs 0.000 claims abstract description 26
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 claims abstract description 25
- 108010093894 Xanthine oxidase Proteins 0.000 claims abstract description 25
- 102100033220 Xanthine oxidase Human genes 0.000 claims abstract description 25
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 claims abstract description 25
- VOLMSPGWNYJHQQ-UHFFFAOYSA-N 3,5-dihydroxy-6-methyl-2,3-dihydropyran-4-one Chemical compound CC1=C(O)C(=O)C(O)CO1 VOLMSPGWNYJHQQ-UHFFFAOYSA-N 0.000 claims abstract description 24
- VQJHOPSWBGJHQS-UHFFFAOYSA-N metoprine, methodichlorophen Chemical compound CC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C(Cl)=C1 VQJHOPSWBGJHQS-UHFFFAOYSA-N 0.000 claims abstract description 23
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 22
- QEWSAPKRFOFQIU-UHFFFAOYSA-N 5-Hydroxy-6,7,3',4'-tetramethoxyflavone Natural products C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C=C2O1 QEWSAPKRFOFQIU-UHFFFAOYSA-N 0.000 claims abstract description 21
- IECRXMSGDFIOEY-UHFFFAOYSA-N Tangeretin Natural products COC=1C(OC)=C(OC)C(OC)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 IECRXMSGDFIOEY-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- HXTFHSYLYXVTHC-AJHDJQPGSA-N narirutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O1 HXTFHSYLYXVTHC-AJHDJQPGSA-N 0.000 claims abstract description 21
- HXTFHSYLYXVTHC-ZPHOTFPESA-N narirutin Natural products C[C@@H]1O[C@H](OC[C@H]2O[C@@H](Oc3cc(O)c4C(=O)C[C@H](Oc4c3)c5ccc(O)cc5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O HXTFHSYLYXVTHC-ZPHOTFPESA-N 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 9
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 25
- 201000005569 Gout Diseases 0.000 claims description 13
- 239000003963 antioxidant agent Substances 0.000 claims description 12
- 201000001431 Hyperuricemia Diseases 0.000 claims description 11
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 claims description 6
- 238000005096 rolling process Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 5
- 235000013376 functional food Nutrition 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 2
- 230000001766 physiological effect Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 41
- 150000008442 polyphenolic compounds Chemical class 0.000 description 25
- 235000013824 polyphenols Nutrition 0.000 description 25
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 24
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 24
- 229940116269 uric acid Drugs 0.000 description 24
- 238000000605 extraction Methods 0.000 description 21
- 208000035874 Excoriation Diseases 0.000 description 20
- 238000005299 abrasion Methods 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 10
- 230000002292 Radical scavenging effect Effects 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- -1 flavonoid compounds Chemical class 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 5
- 241001672694 Citrus reticulata Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 5
- 229930019673 naringin Natural products 0.000 description 5
- 229940052490 naringin Drugs 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- 229940075420 xanthine Drugs 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 240000000560 Citrus x paradisi Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- NLAWPKPYBMEWIR-SKYQDXIQSA-N (2S)-poncirin Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 NLAWPKPYBMEWIR-SKYQDXIQSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 244000089742 Citrus aurantifolia Species 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RMCRQBAILCLJGU-HIBKWJPLSA-N Didymin Chemical compound C1=CC(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 RMCRQBAILCLJGU-HIBKWJPLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- HDOMLWFFJSLFBI-UHFFFAOYSA-N Eriocitrin Natural products CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(Oc4c3)c5ccc(OC6OC(COC7OC(C)C(O)C(O)C7O)C(O)C(O)C6O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O HDOMLWFFJSLFBI-UHFFFAOYSA-N 0.000 description 2
- OMQADRGFMLGFJF-MNPJBKLOSA-N Eriodictioside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O1 OMQADRGFMLGFJF-MNPJBKLOSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OBKKEZLIABHSGY-DOYQYKRZSA-N Neoeriocitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=C(O)C(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O OBKKEZLIABHSGY-DOYQYKRZSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- RMCRQBAILCLJGU-UHFFFAOYSA-N Neoponcirin Natural products C1=CC(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 RMCRQBAILCLJGU-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- NLAWPKPYBMEWIR-VGQRFNKBSA-N Poncirin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C[C@@H](c3ccc(OC)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 NLAWPKPYBMEWIR-VGQRFNKBSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 2
- 229960003459 allopurinol Drugs 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- RPMNUQRUHXIGHK-PYXJVEIZSA-N apigenin 7-O-neohesperidoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=CC(O)=CC=3)OC2=C1 RPMNUQRUHXIGHK-PYXJVEIZSA-N 0.000 description 2
- 229930034861 apigenin-7-O-neohesperidoside Natural products 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229930146541 neoeriocitrin Natural products 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- RPMNUQRUHXIGHK-SBDOOABHSA-N rhoifolin Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C=C(c3ccc(O)cc3)Oc2c1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 RPMNUQRUHXIGHK-SBDOOABHSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940083618 sodium nitroprusside Drugs 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241001140714 Citrus latifolia Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000694496 Citrus reshni Species 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 241000369096 Citrus x microcarpa Species 0.000 description 1
- 244000295848 Citrus x nobilis Species 0.000 description 1
- 235000017102 Citrus x nobilis Nutrition 0.000 description 1
- 241000333459 Citrus x tangelo Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 241000723267 Diospyros Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000173371 Garcinia indica Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 241000700189 Hystrix <Rodentia> Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000354944 Leiocarpa Species 0.000 description 1
- 241001299723 Limonia <Rutaceae> Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- MZNYWPRCVDMOJG-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine dihydrochloride Chemical compound [Cl-].[Cl-].C1=CC=C2C([NH2+]CC[NH3+])=CC=CC2=C1 MZNYWPRCVDMOJG-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 208000020560 abdominal swelling Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- YTAQZPGBTPDBPW-UHFFFAOYSA-N flavonoid group Chemical class O1C(C(C(=O)C2=CC=CC=C12)=O)C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 1
- 229930002879 flavonoid pigment Natural products 0.000 description 1
- 150000004638 flavonoid pigments Chemical class 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009225 memory damage Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical compound [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
- A23L19/07—Fruit waste products, e.g. from citrus peel or seeds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Birds (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 플라보노이드의 함량이 증가된 감귤류 과피 추출물의 제조방법에 관한 것이다.The present invention relates to a method for preparing an extract of citrus fruit with an increased content of flavonoids.
귤, 한라봉 등의 감귤류는 우리나라 남부지방 및 제주도에서 널리 재배되고 있으며, 음료, 감귤 초콜렛 등 감귤류 가공품을 만드는 과정에서 감귤류 과피 및 착즙박 등의 가공부산물이 연간 5만톤 이상 발생되어 폐기물로 버려지고 있다. Citrus fruits such as mandarin oranges and Hallabong are widely cultivated in the southern regions of Korea and Jeju Island.In the process of making citrus fruits such as beverages and citrus chocolate, processed by-products such as citrus peels and juice gourd are generated more than 50,000 tons per year and are discarded as waste. .
감귤의 과피는 “진피”로 불리며 전통적으로 약재로 사용해 왔다. 진피는 기가 뭉친 것을 풀어주고 비장의 기능을 강화하여 복부 창만, 트림, 구토, 메스꺼움, 소화불량, 헛배가 부르고 나른한 증상, 대변이 묽은 증상을 치료한다. 또한 기침, 가래를 없애주며 이뇨작용을 한다.The peel of citrus is called “dermis” and has been traditionally used as a medicinal material. The dermis relieves the lumps of gi and strengthens the function of the spleen to treat abdominal swelling, belching, vomiting, nausea, indigestion, flatulence and drowsy symptoms, and thin stool. It also removes cough and phlegm and is diuretic.
감귤류 과피에 포함된 정유 성분이 소화기자극, 소화촉진, 거담, 항궤양, 항위액 분비, 강심, 혈압상승, 항알레르기, 담즙분비촉진, 자궁평활근 억제, 항균작용 등을 하는 것으로 알려져 있다.Essential oils contained in citrus fruit skin are known to stimulate digestive organs, promote digestion, expectorm, anti-ulcer, secretion of anti-gastric juice, heart rate, increase blood pressure, anti-allergic, promote bile secretion, inhibit uterine smooth muscle, and have antibacterial effects.
이러한 감귤류 과피는 플라보노이드, 펙틴 및 오일 등이 풍부한 것으로 알려져 있다. 감귤류 과피는 건조중량에 대해 1 내지 3%로 플라보노이드를 함유하고 있으며 이들 플라보노이드는 60종 이상으로 알려져 있다.These citrus peels are known to be rich in flavonoids, pectins and oils. Citrus peel contains 1 to 3% of flavonoids based on dry weight, and these flavonoids are known to be more than 60 species.
감귤류에 포함된 주요 플라보노이드 화합물은 루틴(rutin) 및 디오스민(diosimine)과 같은 일반적인 플라보노이드 및 헤스페리딘(hesperidin), 나린진(naringin)과 같은 감귤 특유의 플라보노이드, 그리고 채소나 과일에서는 보고되지 않은 감귤류 고유에서만 발견된 폴리메톡시플라보노이드(polymethoxyflavonoid)인 노빌레틴, 탄제레틴(tangeretin) 등과 같은 플라보노이드가 존재하고 있다. The main flavonoid compounds in citrus fruits are common flavonoids such as rutin and diosmin, and flavonoids specific to citrus fruits such as hesperidin and naringin, and only citrus-specific flavonoids not reported in vegetables or fruits. Flavonoids such as nobiletin and tangeretin, which are the found polymethoxyflavonoids, exist.
헤스페리딘은 감귤류 과일에 많이 존재하는 플라보노이드계 색소 중 플라바논(flavanone) 배당체이다. 지질과산화물 형성을 억제하며 노화지연 등의 항산화 효과, 항염증 효과, 모세혈관 보호 및 항암작용, 콜레스테롤을 낮추는 효과가 알려져 있다. Hesperidin is a flavanone glycoside among the flavonoid pigments present in citrus fruits. It is known to inhibit the formation of lipid peroxide and to reduce cholesterol, as well as anti-oxidative effects such as delaying aging, anti-inflammatory effects, capillary protection and anti-cancer effects.
나리루틴(Narirutin)은 감류 다양한 감귤의 부위에 존재하며, 항산화 효과, 항염증 효과, 기관지 천식치료 및 항암작용, 알코올성 간질환 개선 효과가 알려져 있다. Narirutin is present in various citrus areas of persimmons, and is known for its antioxidant effect, anti-inflammatory effect, bronchial asthma treatment and anticancer effect, and improvement in alcoholic liver disease.
나린진(naringin)은 감귤류의 쓴맛 주성분으로 여름귤이나 자몽에 함유되어 있다. 나린진(naringin)은 간질환에 효과가 좋고, 혈소판 응집 억제, 혈압강하, 지질대사개선 등의 효과가 있다고 알려져 있다.Naringin is the main component of citrus bitter taste and is contained in summer tangerines and grapefruits. Naringin is known to be effective in liver disease, inhibit platelet aggregation, lower blood pressure, and improve lipid metabolism.
탄제레틴(tangeretin)은 암세포들의 접착을 강화시켜서 암세포들이 전이되는 것을 방지하는 효과가 있는 것으로 알려져 있으며, 또한 강력한 항산화와 항염 활성을 나타내는 것으로 알려져 있다. Tangeretin is known to have an effect of preventing metastasis of cancer cells by enhancing adhesion of cancer cells, and is also known to exhibit strong antioxidant and anti-inflammatory activities.
감귤류에서 노빌레틴과 탄제레틴 등을 함유하는 추출물을 제조하는 종래의 방법은 추출 효율이 낮고 장시간이 소요되거나 비용이 많이 들고 에너지의 소비가 높아 산업적으로 적용하기에는 여러 가지 문제점을 안고 있다. 이에, 본 발명자들은 감귤류 과피에서 플라보노이드 함량이 높은 추출물의 제조방법을 제공하고자 한다.The conventional method for preparing an extract containing nobiletin and tangeretin from citrus fruits has a number of problems for industrial application due to low extraction efficiency, long time or high cost, and high energy consumption. Accordingly, the present inventors aim to provide a method for preparing an extract having a high flavonoid content from citrus fruit peel.
본 발명의 목적은 감귤류 과피를 140 내지 155℃의 온도로 덖는 단계를 포함하는, 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 및 시넨세틴(Sinensetin)으로 이루어진 군에서 선택되는 하나 이상의 플라보노이드, 2,3-디하이드로-3,5-디하이드록시-6-메틸-4(H)-피란-4-온(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP)의 함량, 항산화 활성 또는 크산틴 산화효소 저해활성이 증가된 감귤류 과피 추출물의 제조방법을 제공하는 것이다. It is an object of the present invention to Narirutin, Hesperidin, Nobiletin, Tangeretin and Sinensetin, comprising the step of roasting citrus peel to a temperature of 140 to 155°C. At least one flavonoid selected from the group consisting of, 2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one (2,3-dihydro-3,5-dihydroxy It is to provide a method for preparing a citrus peel extract with increased content of -6-methyl-4(H)-pyran-4-one, DDMP), antioxidant activity, or xanthine oxidase inhibitory activity.
본 발명의 다른 목적은 상기의 제조방법으로 제조된 감귤류 과피 추출물을 제공하는 것이다. Another object of the present invention is to provide a citrus fruit peel extract prepared by the above manufacturing method.
본 발명의 또 다른 목적은 상기 감귤류 과피 추출물을 포함하는 항산화용 식품 조성물을 제공하는 것이다. Another object of the present invention is to provide an antioxidant food composition comprising the citrus fruit extract.
본 발명의 또 다른 목적은 감귤류 과피 추출물을 포함하는 항산화용 화장료 조성물을 제공하는 것이다. Another object of the present invention is to provide an antioxidant cosmetic composition comprising a citrus fruit extract.
상기와 같은 본 발명의 목적을 달성하기 위하여, 하나의 양태로 감귤류 과피의 온도가 140 내지 155℃의 온도로 덖는 단계를 포함하는, 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 및 시넨세틴(Sinensetin)으로 이루어진 군에서 선택되는 하나 이상의 플라보노이드 함량, 2,3-디하이드로-3,5-디하이드록시-6-메틸-4(H)-피란-4-온(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP) 함량, 항산화 활성 또는 크산틴 산화효소 저해활성이 증가된 감귤류 과피 추출물의 제조방법을 제공한다.In order to achieve the object of the present invention as described above, Narirutin, hesperidin, nobiletin, including the step of rolling the citrus peel to a temperature of 140 to 155 °C in one embodiment , Tangeretin and sinensetin content of one or more flavonoids selected from the group consisting of, 2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4 -One (2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP) content, antioxidant activity, or xanthine oxidase inhibitory activity of citrus peel extracts Provides a manufacturing method.
본 발명에서 “감귤류”은 운향과 감귤속(Citrus) 식물의 열매로, 가보스(Sphaerocarpa), 가을향(Gaeulhyang), 감자(Benikoji), 광귤(Daidai), 그레이프프루트(Paradisi), 기주귤(Kinokuni), 당귤/오렌지(Sinensis), 당유자(Dangyuja), 동정귤(Erythrosa), 라임?R(Floridana), 랑푸르(Limonia), 레드향(Kanpei), 레몬(Limon), 루미아(Lumia), 리메타(Limetta), 만감(Tangor), 만백유(Banpeiyu), 머콧(Murcott), 메이어레몬(Meyeri), 미니향(Minihyang), 베르가못(Bergamia), 병감(Poonensis), 병귤(Platymamma), 불수감(Sarcodactylis), 블러드라임(Blood Lime), 블러드오렌지(Blood Orange), 비차리아(Bizzaria), 빈귤(Leiocarpa), 사두감(Pseudogulgul), 서지향(Nishinokaori), 시콰사(Depressa), 시트렌지(Insitorum), 쓴귤(Aurantium), 야파오렌지(Jaffa), 어글리(Ugli), 에트로그(Ethrog), 영귤(Sudachi), 오로블랑코(Oroblanco), 온주귤(Unshiu), 왕귤(King), 윈터프린스(Winter Prince), 유감(Suavissima), 유엽귤(Deliciosa), 유자(Junos), 이예감(Iyo), 인도라임(Limettioides), 일향하귤(Tamurana), 자바라(Jabara), 지각(Jigak), 지아미르(Jambhiri), 진귤(Sunki), 진지향(Tsunokaori), 천혜향(Setoka), 청견(Kiyomi), 청귤(Nippokoreana), 카라카라오렌지(Cara Cara), 카피르라임(Hystrix), 칼라만시(Microcarpa), 칼피(Webberi), 클레멘타인(Clementina), 클레오파트라귤(Reshni), 키노토(Myrtifolia), 키라임(Aurantiifolia), 킨누(Kinnow), 탄제린(Tangerina), 탄젤로(Tangelo), 팔삭(Hassaku), 페르시아라임(Latifolia), 편귤(Pyeongyul), 폰데로사(Pyriformis), 하귤(Natsudaidai), 하례귤(Unshiu), 한라봉(Shiranuhi), 한라향(Setomi), 홍귤(Tachibana) 및 황금향(Beni Madonna), 자몽(grapefruit)으로 이루어진 군에서 선택되는 1종 이상일 수 있다.In the present invention, "citrus" refers to the fruit of a plant of luck and citrus (Citrus), Gabos (Sphaerocarpa), autumn scent (Gaeulhyang), potato (Benikoji), light orange (Daidai), grapefruit (Paradisi), Giju mandarin ( Kinokuni), Tangerine/Orange (Sinensis), Dangyuja, Erythrosa, Lime R (Floridana), Limonia, Kanpei, Lemon, Lumia , Limetta, Tangor, Banpeiyu, Murcott, Meyer Lemon, Minihyang, Bergamot, Poonensis, Platymamma, Sarcodactylis, Blood Lime, Blood Orange, Bizzaria, Leiocarpa, Pseudogulgul, Nishinokaori, Depressa, Citrus (Insitorum), Aurantium, Jaffa, Ugli, Ethrog, Sudachi, Oroblanco, Unshiu, King Tangerine, Winter Prince (Winter Prince), Suavissima, Deliciosa, Junos, Iyo, Limettioides, Tamuraana, Jabara, Jigak, Jia Jambhiri, Sunki, Tsunokaori, Setoka, Kiyomi, Nippokoreana, Cara Cara, Hystrix, Calamansi Microcarpa), Webberi, Clementina, Cleopatragul (Reshni), Kinoto (Myrtifolia), Key Lime ( Aurantiifolia), Kinnow, Tangerina, Tangelo, Hassaku, Persian lime (Latifolia), Pyeongyul, Pyriformis, Natsudaidai, Harye orange It may be one or more selected from the group consisting of (Unshiu), Hallabong (Shiranuhi), Hallahyang (Setomi), Tachibana and Goldenhyang (Beni Madonna), and grapefruit.
본 발명에서 “과피”는 감귤류 열매의 껍질로 진피로도 불린다. 감귤류 과피는 카로티노이드(carotenoid) 류, 플라보노이드(flavonoid) 류, 펙틴(pectin) 및 테프펜(terpene) 류가 풍부하게 함유되어 있다.In the present invention, the "peel" is the peel of a citrus fruit and is also called a dermis. Citrus peel is rich in carotenoids, flavonoids, pectin and terpene.
본 발명에서 “추출”은 식물이나, 광물 등 여러 성분을 이루고 있는 물질에서 특정한 성분만을 녹여서 얻는 방법으로, 본 발명에서는 감귤류 과피에서 물, 탄소수 1 내지 4의 알코올 용매 및 이들의 혼합용매로 이루어진 군에서 선택되는 하나의 용매를 이용하여 생리활성 물질을 녹여서 추출하는 것을 의미한다. 상기 생리활성 물질은 구체적으로 플라보노이드일 수 있다. In the present invention, "extraction" is a method obtained by dissolving only specific components in a substance consisting of various components such as plants or minerals. In the present invention, a group consisting of water, an alcohol solvent having 1 to 4 carbon atoms, and a mixed solvent thereof from citrus fruit peel It means extracting by dissolving a physiologically active substance using one solvent selected from. Specifically, the bioactive substance may be a flavonoid.
본 발명에서 “플라보노이드”는 식물이나 균류의 이차대사산물의 일종으로, 화학식 1과 같이 두 개의 페닐 고리(A와 B)와 헤테로 사이클릭 고리(C)로 구성된 15개의 탄소 골격의 구조를 가진다. In the present invention, “flavonoid” is a kind of secondary metabolite of plants or fungi, and has a structure of 15 carbon skeletons consisting of two phenyl rings (A and B) and a heterocyclic ring (C) as shown in Formula 1.
상기 플라보노이드는 나리루틴(Naritutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 및 시넨세틴(Sinensetin)으로 이루어진 군에서 선택되는 어느 하나의 플라보노이드일 수 있다.The flavonoid may be any one flavonoid selected from the group consisting of Naritutin, Hesperidin, Nobiletin, Tangeretin, and Sinensetin.
본 발명에서 “나리루틴(Naritutin)”은 감귤과피에 다량 포함되어 있는 플라보노이드로 화학식2의 구조를 가진다. 상기 나리루틴은 감귤 이외의 야채나 과일에서는 보고되지 않으며, 항산화 효과, 항염증 효과, 기관지 천식치료 및 항암작용, 알코올성 간질환 개선 효과를 가진다고 알려져 있다.In the present invention, “Naritutin” is a flavonoid contained in a large amount of citrus fruits and has the structure of Formula 2. Nariroutine is not reported in vegetables or fruits other than citrus fruits, and is known to have antioxidant effects, anti-inflammatory effects, bronchial asthma treatment and anticancer effects, and alcoholic liver disease improvement effects.
본 발명에서 “헤스페리딘(hesperidin)”은 감귤류에서 발견되는 플라보노이드의 일종으로, 화학식 3의 구조를 가지는 플라보논의 배당체이다. 헤스페리딘은 모세혈관의 강화, 출혈 예방, 혈압 조정 등의 생리작용을 지니며, 황색색소로서 옛날부터 알려져 있으며 식품, 의약품, 화장품 등에 이용되고 있다.In the present invention, "hesperidin" is a kind of flavonoid found in citrus fruits, and is a glycoside of flavonones having the structure of formula (3). Hesperidin has physiological actions such as strengthening capillaries, preventing bleeding, and adjusting blood pressure. Hesperidin has been known since ancient times as a yellow pigment and is used in foods, medicines, and cosmetics.
본 발명에서 “노빌레틴(Nobiletin)”은 감귤과피에 다량 포함되어 있는 플라보노이드로 화학식 4의 구조를 가진다. 상기 노빌레틴은 감귤 이외의 야채나 과일에서는 보고되지 않으며, 결장암에 대해 항암 작용을 발휘하고, 기관지 천식에 대한 치료제로써 작용하며, 메모리 손상에 대한 회복효과를 가진다고 알려져 있다. In the present invention, "Nobiletin" is a flavonoid contained in a large amount of citrus fruits and has the structure of Formula 4. The nobiletin is not reported in vegetables or fruits other than citrus fruits, exerts anticancer action against colon cancer, acts as a therapeutic agent for bronchial asthma, and is known to have a recovery effect against memory damage.
본 발명에서 “탄게레틴(Tangeretin)”은 감귤류 열매의 과피(껍질)에 주로 농축되어 있는 폴리메톡시플라보노이드(polymethoxyflavonoid)로 화학식5의 구조를 가지며, 항암활성 및 항산화 활성이 있다고 알려져 있다.In the present invention, "Tangeretin" is a polymethoxyflavonoid that is mainly concentrated in the peel (skin) of citrus fruits, and has a structure of Formula 5, and is known to have anticancer and antioxidant activities.
본 발명에서 “시넨세틴(Sinensetin)”은 메틸화된 플라본(methylated flavone)으로 화학식6의 구조를 가지며, 오렌지 오일에 많이 함유되어 있고, 항염증, 항바이러스 등의 효능이 알려져 있다.In the present invention, "Sinensetin" is a methylated flavone, has the structure of Formula 6, is contained in orange oil, and has anti-inflammatory and antiviral effects.
본 발명에서 “DDMP(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one)”는 화학식7의 구조를 가지며, 항산화, 항암 등의 효능이 알려져 있다. In the present invention, “DDMP(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one)” has a structure of Formula 7, and its anti-oxidation and anti-cancer effects are known. have.
본 발명에서 “덖는 단계”는 감귤과피에 열이 전달되는 온도가 140 내지 155℃의 온도로 기름 없이 볶아서 익히는 것을 특징으로 한다.In the present invention, the “roasting step” is characterized in that the citrus peel is roasted and cooked without oil at a temperature of 140 to 155°C at which heat is transferred.
상기 덖는 단계는 구체적으로 감귤과피의 전달 온도가 120 내지 155℃에서 유지되는 온도로 60 이상 RPM으로 10 내지 60분 동안 수행될 수 있으며, 이는 감귤과피의 온도를 전달하기 위해 설정된 장비의 온도설정에 따라 달라질 수 있다. The roasting step may be performed for 10 to 60 minutes at a temperature of at least 60 RPM at a temperature in which the delivery temperature of the citrus peel is maintained at 120 to 155°C, and this can be performed for 10 to 60 minutes at a temperature of the citrus peel. It can be different.
더욱 구체적으로 250℃ 온도로 감귤과피의 온도가 155℃의 온도에 도달하도록 90 RPM으로 10 내지 43분 동안 수행될 수 있다. More specifically, it may be performed for 10 to 43 minutes at 90 RPM so that the temperature of the citrus peel reaches a temperature of 155°C at a temperature of 250°C.
상기 덖음온도에서 과피온도가 140℃ 미만인 경우, 플라보노이드의 증가 효과가 낮아 효율성이 떨어지며, 160℃를 초과한 경우 감귤류 과피가 타는 문제가 발생할 수 있다.In the case where the pericarp temperature is less than 140° C. at the roasting temperature, the effect of increasing flavonoids is low, and efficiency decreases, and when it exceeds 160° C., a problem of burning citrus peel may occur.
상기 덖음 시 RPM이 60 RPM 미만인 경우, 덖는 속도가 오래 걸리는 문제가 발생할 수 있으며, 그 이상일 경우는 과피가 타지 않는 범위에서 속도조절이 가능하다. If the RPM is less than 60 RPM during the abrasion, a problem may occur that the rolling speed takes a long time, and in the case of more than that, the speed can be adjusted within a range in which the skin does not burn.
상기 덖음 시간이 90 RPM을 기준으로 10분 미만인 경우, 온도 전달율이 낮아 원료를 추출할 때 추출효율이 낮고, 색과 향이 달달하고 고소하지 아니한 문제가 있으며, 과피 온도가 160℃ 이상에 도달하면 색이 검고 탄맛이 너무 강한 문제가 발생할 수 있다. When the roasting time is less than 10 minutes based on 90 RPM, the temperature transfer rate is low, so when extracting raw materials, the extraction efficiency is low, the color and scent are sweet, and there is a problem of not savory. This black and tan taste can cause problems that are too strong.
본 발명의 실시예에서 덖음온도에 따른 감귤 과피의 추출물의 추출수율, 항산화 활성, 총 폴리페놀 함량, 플라보노이드 함량 및 DDMP 함량 변화를 확인하고자, 250℃상에서 감귤과피가 100 내지 155℃에 도달하도록 90 PRM로 덖음 처리하였으며, 덖음 처리한 감귤과피에 물을 첨가하고 100℃로 가열하여 1시간 동안 열수 추출하여 추출물을 제조하였다. 그 후 각 추출물의 추출수율, 항산화 활성, 크산틴 산화효소 저해활성, 총 폴리페놀 함량, 플라보노이드 함량, DDMP 함량을 분석하였다. In an embodiment of the present invention, in order to confirm the change in the extraction yield, antioxidant activity, total polyphenol content, flavonoid content and DDMP content of the extract of citrus peel according to the roasting temperature, at 250° C., the citrus peel reaches 100 to 155° C. The extract was prepared by roasting with PRM, adding water to the roasted citrus peel, heating to 100°C, and hot water extraction for 1 hour. Then, the extraction yield, antioxidant activity, xanthine oxidase inhibitory activity, total polyphenol content, flavonoid content, and DDMP content of each extract were analyzed.
추출수율 분석결과, 100 내지 155℃로 덖음 처리한 감귤 과피의 추출수율은 덖음 온도가 증가함에 따라 증가함을 확인하였다. 구체적으로, 무처리 시료는 추출수율이 22.4%로 측정되었으며, 155℃로 덖음 처리한 처리한 감귤과피에서 추출수율이 31.0%로 측정되어 덖음 처리에 의해 추출수율이 8.6% 증가함을 확인하였다.As a result of the extraction yield analysis, it was confirmed that the extraction yield of citrus peels treated with roasting at 100 to 155°C increased as the roasting temperature increased. Specifically, the extraction yield of the untreated sample was measured as 22.4%, and the extraction yield was measured as 31.0% from the treated citrus peels treated with roasting at 155°C, confirming that the extraction yield increased by 8.6% by the roasting treatment.
항산화 활성 분석결과, 무처리 시료와 비교하여 덖음 처리한 시료에서 항산화 활성이 증가하는 경향을 보였으며, 덖음 온도가 증가함에 따라 항산화 활성이 증가하였다. 구체적으로, 155℃에서 덖음 처리한 감귤껍질 추출물이 DPPH 또는 ABTS 라디칼 소거활성, 크산틴 산화효소 저해 활성이 증가하였다. As a result of the antioxidant activity analysis, the anti-oxidant activity tended to increase in the sample treated with roasting compared to that of the untreated sample, and the antioxidant activity increased as the roasting temperature increased. Specifically, the extract of citrus peel treated with roasting at 155°C increased DPPH or ABTS radical scavenging activity and xanthine oxidase inhibitory activity.
총 폴리페놀 함량 분석결과, 덖음 온도가 높을수록 총 폴리페놀 함량이 높음을 확인하였다. 구체적으로, 덖음온도 100 내지 120℃에서는 총 폴리페놀 함량이 무처리 시료보다 10.9% 내지 12.3% 증가하였고, 덖음 온도 140 내지 155℃에서 무처리 시료와 비교하여 총 폴리페놀 함량이 43.4 내지 74.9%로 증가하였다. 이중 155℃에서 덖은 시료의 총 폴리페놀 함량이 무처리 대조군과 비교하여 74.9% 증가하여 폴리페놀의 함량이 가장 높음을 확인하였다. As a result of analyzing the total polyphenol content, it was confirmed that the higher the roasting temperature, the higher the total polyphenol content. Specifically, the total polyphenol content increased by 10.9% to 12.3% compared to the untreated sample at a roasting temperature of 100 to 120°C, and the total polyphenol content was 43.4 to 74.9% compared to the untreated sample at a roasting temperature of 140 to 155°C. Increased. Among them, the total polyphenol content of the sample roasted at 155°C increased 74.9% compared to the untreated control group, confirming that the polyphenol content was the highest.
따라서, 140 내지 155℃에서 덖음 처리하는 것이 총 폴리페놀 함량 증가에 효과적임을 확인하였고, 155℃가 폴리페놀을 증가시키는 우수한 덖음 온도 조건임을 확인하였다. Therefore, it was confirmed that the roasting treatment at 140 to 155°C was effective in increasing the total polyphenol content, and it was confirmed that 155°C was an excellent roasting temperature condition for increasing the polyphenol.
플라보노이드인 나리루틴((Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 또는 시넨세틴(Sinensetin) 함량을 분석한 결과, 덖음처리 온도가 증가함에 따라 플라보노이드의 함량이 증가함을 확인하였다.As a result of analyzing the content of flavonoids, Narirutin, Hesperidin, Nobiletin, Tangeretin, or Sinensetin, the content of flavonoids increased as the aching temperature increased. Was confirmed.
구체적으로, 140℃ 내지 155℃의 덖음 처리한 감귤과피에서 플라보노이드인 나리루틴((Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 및 시넨세틴(Sinensetin)이 함량이 100 내지 120℃에서 덖은 처리한 시료보다 높음을 확인하였으며, 155℃에서 덖음 처리한 감귤과피에서 나리루틴((Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin) 및 시넨세틴(Sinensetin) 함량이 가장 높음을 확인하였다. Specifically, the content of flavonoids Narirutin (Narirutin), hesperidin, nobiletin, and Sinensetin in the roasted citrus peel at 140°C to 155°C is in the range of 100 to 120°C. Was confirmed to be higher than that of the treated sample, and it was confirmed that the contents of Narirutin, Hesperidin, Nobiletin, and Sinensetin were the highest in citrus peels treated with roasting at 155°C.
탄게레틴(Tangeretin)의 함량은 무처리 시료에서 0.09mg/g으로 측정되었으며, 100 내지 120℃에서 0.09mg/g 내지 0.10mg/g로 측정되었고, 140 내지 155℃ 처리한 시료에서 0.10mg/g 내지 0.12mg/g로 증가하였고, 155℃에서 0.12mg/g으로 가장 함량이 높았다.The content of Tangeretin was measured as 0.09 mg/g in the untreated sample, 0.09 mg/g to 0.10 mg/g at 100 to 120°C, and 0.10 mg/g in the sample treated at 140 to 155°C. To 0.12mg/g, and the highest content was 0.12mg/g at 155°C.
즉, 140 내지 155℃에서 덖음 처리하였을 때, 감귤껍질의 나리루틴((Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 또는 시넨세틴(Sinensetin)의 함량이 무처리 시료 및 100 내지 120℃에서 덖음 시료보다 우수함을 확인하였으며, 이중 155℃에서 덖음 시료가 플라보노이드 함량이 가장 높음을 확인하였다.That is, when the abrasion treatment was performed at 140 to 155°C, the content of the citrus peel Narirutin, Hesperidin, Nobiletin, Tangeretin, or Sinensetin was untreated. And it was confirmed that it is superior to the roasted sample at 100 to 120°C, of which it was confirmed that the roasted sample at 155°C had the highest flavonoid content.
DDMP 함량 변화 분석결과, 덖음처리에 의해 DDMP 함량이 증가하는 것을 확인하였으며, 덖음처리 온도가 증가할수록 DDMP 함량이 증가함을 확인하였다. 구체적으로 DDMP는 초기 건조된 시료에서 소량 확인되었으나 140℃내지 155℃ 온도에서 크게 증가함을 확인하였다. 덖음 온도에 따른 DDMP(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one)의 함량을 분석한 결과, 0℃에서 155℃온도에 도달할 때까지 덖음 온도가 증가할수록 함량도 증가하는 것을 확인하였다. 구체적으로 0.20mg/g로 다른 열처리 시료에 비하여 소량이 검출되었고 120℃에서 1.83mg/g이 생성되었다. 그리고 140℃에서 9.83mg/g이 생성되어, 155℃에서는 19.17mg/g으로 가장 높은 함량을 확인하였다. As a result of analyzing the change in DDMP content, it was confirmed that the DDMP content increased by the abrasion treatment, and it was confirmed that the DDMP content increased as the temperature of the abrasion treatment increased. Specifically, a small amount of DDMP was found in the initially dried sample, but it was confirmed that it increased significantly at a temperature of 140°C to 155°C. As a result of analyzing the content of DDMP (2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one) according to the roasting temperature, when the temperature reaches 155°C from 0℃ It was confirmed that the content increased as the roasting temperature increased. Specifically, a small amount of 0.20mg/g was detected compared to other heat treatment samples, and 1.83mg/g was produced at 120°C. And 9.83mg/g was produced at 140℃, and the highest content was confirmed as 19.17mg/g at 155℃.
즉, 140 내지 155℃에서 덖음 처리하였을 때, 감귤껍질의 DDMP 함량이 무처리 시료 및 100 내지 120℃에서 덖음 시료보다 우수함을 확인하였으며, 이중 155℃에서 덖음 시료가 DDMP 함량이 가장 높음을 확인하였다.That is, when the roasting treatment was performed at 140 to 155°C, it was confirmed that the DDMP content of the citrus peel was superior to that of the untreated sample and the roasted sample at 100 to 120°C, of which it was confirmed that the roasted sample at 155°C had the highest DDMP content. .
따라서 140 내지 155℃, 구체적으로 155℃로 덖음 처리하여 제조한 감귤과피 추출물은 추출효율이 개선되며, 항산화 효과, 총 폴리페놀 함량, 플라보노이드 함량 또는 DDMP 함량이 증가된 것을 특징으로 한다. Therefore, the citrus peel extract prepared by roasting at 140 to 155°C, specifically 155°C, is characterized in that the extraction efficiency is improved, and the antioxidant effect, total polyphenol content, flavonoid content, or DDMP content is increased.
또한 140 내지 155℃, 구체적으로 155℃로 덖음 처리하여 제조한 감귤과피 추출물 은 크산틴 산화효소 저해 활성이 증가된 것을 특징으로 한다. In addition, the citrus peel extract prepared by roasting at 140 to 155°C, specifically 155°C is characterized by increased xanthine oxidase inhibitory activity.
본 발명에서 “크산틴 산화효소”는 크산틴을 기질로 하여 요산를 생성하는 과정에서 초과산화 라디칼을 생성하는 효소이다. 생체 내에서 유리기 생성계의 하나인 크산틴 산화효소는 푸린(purine), 피리미딘 프테리딘 알데하이드(pyrimidine pteridine aldehyde) 및 헤테로싸이클릭 컴파운드(heterocyclic compound) 등의 대사에 관여하는 비특이적 효소로서 생체 내에서 주로 푸린(purine)체의 대사산물인 하이포크산틴(hypoxanthine)을 크산틴으로, 크산틴을 요산으로 산화시키는 반응을 촉매한다.In the present invention, “xanthine oxidase” is an enzyme that generates excess oxidation radicals in the process of producing uric acid using xanthine as a substrate. Xanthine oxidase, one of the free radical generation systems in vivo, is a non-specific enzyme involved in the metabolism of purine, pyrimidine pteridine aldehyde, and heterocyclic compounds. It catalyzes the reaction of oxidizing hypoxanthine, a metabolite of purine, to xanthine and xanthine to uric acid.
요산이 정상보다 많이 생성될 경우 또는 신장이 요산을 배설시키는 능력이 저하될 경우 혈액 중에 여분의 요산이 남아있게 되고 혈중요산치를 높여 고요산혈증 또는 통풍의 발병에 관여한다.When uric acid is produced more than normal, or when the kidney's ability to excrete uric acid decreases, excess uric acid remains in the blood and increases blood uric acid levels, leading to hyperuricemia or gout.
본 발명의 감귤과피 추출물은 덖음처리하지 않은 감귤과피와 비교하여 크산틴 산화효소(xanthine oxidase) 저해 활성이 증가하여 혈중 또는 뇨중의 요산을 감소시켜 통풍 또는 고요산혈증의 예방 또는 개선 효과가 우수하다. The citrus peel extract of the present invention has an increased xanthine oxidase inhibitory activity compared to unsalted citrus peel, thereby reducing uric acid in blood or urine, and thus has excellent preventive or ameliorating effects of gout or hyperuricemia.
본 발명에서 “고요산혈증(Hyperuricemia)”란 혈액에 요산의 농도가 증가되어 있다는 말이다. 이는 혈청에서 모노소디움 요산염의 농도가 제한된 용해도의 한계를 넘을 때 발생한다. 37℃에서 혈장의 요산 포화도는 약 7mg/dl이다. 그러므로 이 농도를 넘으면 물리화학적으로 과포화 상태가 된다. 혈청 요산 농도는 정상인의 평균 혈청 요산 농도보다 +2 표준편차를 초과한 경우에 상대적으로 높은 것으로 알려져 있다. 대부분의 역학 조사에서 남자의 상위 한계는 7mg/dl, 여자는 6mg/이다. 이러한 이유 때문에 고요산혈증이 실질적인 상위 한계 수준은 7.0mg/dl 이상인 경우로 정의되고 있다.In the present invention, "Hyperuricemia" means that the concentration of uric acid in the blood is increased. This occurs when the concentration of monosodium urate in the serum exceeds the limited solubility limit. Plasma uric acid saturation at 37°C is about 7mg/dl. Therefore, when this concentration is exceeded, it becomes physicochemically supersaturated. Serum uric acid concentration is known to be relatively high when it exceeds +2 standard deviation than the average serum uric acid concentration in normal subjects. In most epidemiological studies, the upper limit for men is 7 mg/dl and 6 mg/ for women. For this reason, the actual upper limit level of hyperuricemia is defined as 7.0 mg/dl or more.
본 발명에서 “통풍(Gout)”는 혈액 중에 요산이 높은 상태로 오래 지속되어 형성되는 요산의 결정체가 몸 밖으로 배출되지 못하고, 여러 조직에 쌓여 다양한 증상을 유발하는 대사성 질환이다. 혈중 요산이 증가하는 경우는 과도한 요산의 생산과 신장을 통한 배설 과정의 이상 때문에 제대로 배출되지 못해서 나타날 수 있다. 혈중 요산 수치가 높다고 해서 바로 통풍으로 발병하는 것은 아니고, 높은 요산 수치에 의해 요산 결정체가 쉽게 형성되어 여러 조직에 침착된 상태가 10~20년간 지속되면 유발 인자에 의해 통풍을 일으키게 된다. 이는 주로 40~50대 남성에서 흔하지만 식생활 변화 및 환경변화에 따라 발병 연령이 점점 낮아지고 있으며, 여성은 폐경기 이후 혹은 장기이식 수술 후 면역 저해제를 장기 복용하거나 이뇨제의 장기 복용으로 신기능이 저하된 여성에게서 발병할 가능성이 높다.In the present invention, “Gout” is a metabolic disease in which crystals of uric acid formed by a long-lasting state in a state of high uric acid in the blood cannot be discharged out of the body, and accumulate in various tissues and cause various symptoms. Increased levels of uric acid in the blood may be caused by excessive uric acid production and improper excretion due to abnormalities in the excretion process through the kidneys. A high uric acid level in the blood does not immediately cause gout, and uric acid crystals are easily formed by the high uric acid level, and if the state of deposit in various tissues persists for 10 to 20 years, gout is caused by the triggering factor. This is mostly common in men in their 40s to 50s, but the age of onset is gradually lowering due to changes in diet and environment, and women who take long-term immunosuppressants after menopause or after organ transplant surgery, or women whose renal function has declined due to long-term use of diuretics. It is more likely to develop from
본 발명에서 “개선”은 상기의 제조방법에 의해 제조된 감귤류 과피 추출물을 유효성분으로 포함하는 식품 조성물을 이용하여 고요산혈증 또는 통풍의 의심 및 발병 개체의 증상이 호전되거나 이롭게 되는 모든 행위를 말한다. In the present invention, "improvement" refers to any action that improves or benefits the symptoms of an individual with suspicion of hyperuricemia or gout by using a food composition containing the citrus pericarp extract prepared by the above manufacturing method as an active ingredient.
본 발명에서 “예방”은 본 발명에 따른 조성물의 투여로 상기 고요산혈증 또는 통풍의 발병을 억제 또는 지연시키는 모든 행위를 의미한다. In the present invention, "prevention" refers to any action that suppresses or delays the onset of hyperuricemia or gout by administration of the composition according to the present invention.
본 발명의 다른 실시예에서 덖음처리에 의해 5-하이드록시메틸푸르루랄(5-(Hydroxymethyl)furfural, 5-HMF)의 함량이 증가하는 것을 확인하였으며, 덖음처리 온도가 증가할수록 5-HMF 함량이 증가함을 확인하였다. In another embodiment of the present invention, it was confirmed that the content of 5-hydroxymethylfurfural (5-(Hydroxymethyl)furfural, 5-HMF) increased by the abrasion treatment, and the 5-HMF content increased as the abrasion treatment temperature increased. It was confirmed that it increased.
덖음 온도에 따른 5-HMF 의 함량을 분석한 결과, 100℃ 5-HMF 가 검출되지 않으며, 120℃에서 0.16mg/g로 120℃ 이상에서 5-HMF가 생성됨을 확인하였다. As a result of analyzing the content of 5-HMF according to the roasting temperature, it was confirmed that 5-HMF was not detected at 100°C, and 5-HMF was produced at 120°C or higher at 0.16mg/g at 120°C.
구체적으로 140℃ 내지 155℃에서 2.98 내지 16.77mg/g로 생성되어 덖음 온도가 증가함에 따라 5-HMF의 함량이 증가함을 확인하였다. 또한, 155℃에서 16.77mg/g로 함량이 가장 높음을 확인하였다.Specifically, it was confirmed that the content of 5-HMF increased as the abrasion temperature increased as it was produced at 2.98 to 16.77mg/g at 140°C to 155°C. In addition, it was confirmed that the content was the highest at 16.77mg/g at 155°C.
즉, 140 내지 155℃에서 덖음 처리하였을 때, 감귤껍질의 5-HMF 함량이 무처리 시료 및 100 내지 120℃에서 덖음 시료보다 우수함을 확인하였으며, 이중 155℃에서 덖음 시료가 5-HMF 함량이 가장 높음을 확인하였다.That is, when roasting at 140 to 155°C, it was confirmed that the 5-HMF content of the citrus peel was superior to that of the untreated sample and the roasted sample at 100 to 120°C. Of these, the roasted sample at 155°C had the most 5-HMF content. It was confirmed that it was high.
따라서 본 발명의 제조방법에 의해 제조된 감귤껍질 추출물은 동시에 5-하이드록시메틸푸르루랄(5-(Hydroxymethyl)furfural, 5-HMF)의 함량이 증가된 것을 특징으로 한다. Therefore, the citrus peel extract prepared by the method of the present invention is characterized by an increased content of 5-hydroxymethylfurfural (5-(Hydroxymethyl)furfural, 5-HMF) at the same time.
본 발명에서 “5-히드록시메탈푸르푸랄(5-(Hydroxymethyl)furfural, 5-HMF”은 화학식8의 구조를 가지며, 항산화, 항암 등의 효능이 알려져 있다.In the present invention, “5-(Hydroxymethyl)furfural, 5-HMF” has the structure of Chemical Formula 8, and is known to have anti-oxidation and anti-cancer effects.
본 발명의 다른 양태로 상기의 제조방법으로 제조된 감귤류 과피 추출물을 제공한다. In another aspect of the present invention, it provides a citrus fruit extract prepared by the above manufacturing method.
본 발명의 감귤류 과피 추출물은 감귤류 과피를 140 내지 155℃의 온도로 덖는 단계를 포함하는 제조방법에 의해 제조될 수 있으며, 구체적으로 감귤과피가 140 내지 155℃의 온도로 도달하기 위해 60 RPM 이상으로 덖어 제조되는 것일 수 있으며, 더욱 구체적으로 155℃에서 90 RMP으로 10 내지 43분 동안 덖어 제조될 수 있다.Citrus fruit peel extract of the present invention can be prepared by a manufacturing method comprising the step of roasting the citrus peel at a temperature of 140 to 155 ℃, specifically citrus peel to reach a temperature of 140 to 155 ℃ 60 RPM or more It may be prepared by roasting, and more specifically, it may be prepared by roasting for 10 to 43 minutes at 90 RMP at 155°C.
전술한 실시예에서 감귤 과피 추출물이 덖음처리에 의해 총 폴리페놀 함량, 항산화 활성 및 플라보노이드 함량이 증가하는 것을 확인하였는바, 본 발명의 감귤과피 추출물은 무처리 감귤껍질과 비교하여 총 폴리페놀 함량, 항산화 활성, DDMP, 5-HMF 또는 플라보노이드 함량이 증가된 것을 특징으로 한다. In the above-described examples, it was confirmed that the total polyphenol content, antioxidant activity, and flavonoid content were increased by the roasting treatment of the citrus peel extract, and the total polyphenol content of the citrus peel extract of the present invention was compared with the untreated citrus peel, It is characterized by increased antioxidant activity, DDMP, 5-HMF or flavonoid content.
따라서 상기 폴리페놀은 플라보노이드일 수 있으며, 더욱 구체적으로 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 및 시넨세틴(Sinensetin)로 이루어진 군에서 선택되는 하나 이상의 플라보노이드일 수 있다. Therefore, the polyphenol may be a flavonoid, and more specifically, one or more flavonoids selected from the group consisting of Narirutin, Hesperidin, Nobiletin, Tangeretin, and Sinensetin. Can be
상기와 같이 덖음 처리에 의해 감귤류 과피 추출물에서 생리활성 물질인 플라보노이드 함량이 증가하고, 항산화 효과가 증가함을 확인하였는바, 상기 감귤류 과피 추출물을 항산화 용도로 식품 조성물 및 화장료 조성물로 이용할 수 있다.As described above, it was confirmed that the content of flavonoids, which are physiologically active substances, and the antioxidant effect in the citrus peel extract increased by the roasting treatment as described above, and the citrus peel extract can be used as a food composition and a cosmetic composition for antioxidant purposes.
본 발명의 다른 양태로 상기 감귤류 과피 추출물을 포함하는 항산화용 식품 조성물을 제공한다. In another aspect of the present invention, it provides an antioxidant food composition comprising the citrus fruit extract.
본 발명에서 감귤류 과피 추출물에 대한 설명은 전술한 바와 같다.The description of the citrus peel extract in the present invention is as described above.
전술한 실시예에서 상기 제조방법에 의해 제조된 감귤류 과피 추출물에서 요산 생성에 관여하는 크산틴 산화효소의 저해 활성이 증가하는 것을 확인하였는바, 본 발명의 식품 조성물은 고요산혈증 또는 통풍의 개선 또는 예방용으로 이용 가능하다. In the above-described embodiment, it was confirmed that the inhibitory activity of xanthine oxidase involved in uric acid production was increased in the citrus fruit skin extract prepared by the above manufacturing method, and the food composition of the present invention improved or prevented hyperuricemia or gout. It is available for use.
상기 항산화용 식품 조성물은 식품 제조시 통상적으로 첨가되는 성분, 예를 들면, 단백질, 탄수화물, 지방, 영양소, 조미제 및 향미제를 추가로 포함할 수 있다. The antioxidant food composition may further include ingredients commonly added during food production, such as proteins, carbohydrates, fats, nutrients, flavoring agents, and flavoring agents.
상기 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 사이클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 향미제로서 천연 향미제 [타우마틴, 스테비아 추출물 (예를 들어 레바우디오시드 A, 글리시르히진 등]) 및 합성 향미제(사카린, 아스파르탐 등)를 사용할 수 있다.Examples of the carbohydrate include monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, oligosaccharides, and the like; And polysaccharides, for example, common sugars such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents, natural flavoring agents [taumatin, stevia extract (eg, rebaudioside A, glycyrrhizin, etc.]) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used.
예컨대, 본 발명의 식품 조성물이 드링크제로 제조되는 경우에는 구연산, 액 상과당, 설탕, 포도당, 초산, 사과산, 과즙, 두충 추출액, 대추 추출액, 감초 추출액 등을 추가로 포함시킬 수 있다.For example, when the food composition of the present invention is prepared as a drink, it may further include citric acid, liquid fructose, sugar, glucose, acetic acid, malic acid, fruit juice, headworm extract, jujube extract, licorice extract, and the like.
상기 식품 조성물은 항산화용, 고요산혈증 또는 통풍 개선 또는 예방용 건강기능식품일 수 있다. The food composition may be a health functional food for improving or preventing antioxidant, hyperuricemia, or gout.
본 발명의 건강기능식품은 상기 식품 조성물을 포함한 음료(차 또는 알콜성 음료 포함), 과실 및 그의 가공식품(예: 과일통조림, 병조림, 잼, 마아말레이드 등), 어류, 육류 및 그 가공식품 (예: 햄, 소시지, 콘드비프 등), 빵류 및 면류(예: 우동, 메밀국수, 라면, 스파게티, 마카로니 등), 과즙, 각종 드링크, 쿠키, 엿, 유제품(예: 버터, 치즈 등), 식용식물유지, 마가린, 식물성 단백질, 레토르트 식품, 냉동식품, 각종 조미료(예: 된장, 간장, 소스 등) 등일 수 있다.The health functional food of the present invention includes beverages (including tea or alcoholic beverages), fruits and processed foods thereof (eg, canned fruit, bottled, jam, marmalade, etc.), fish, meat, and processed foods thereof, including the food composition. (E.g. ham, sausage, corned beef, etc.), breads and noodles (e.g. udon, soba, ramen, spaghetti, macaroni, etc.), fruit juice, various drinks, cookies, syrup, dairy products (e.g. butter, cheese, etc.), It may be edible vegetable oil, margarine, vegetable protein, retort food, frozen food, various seasonings (eg, miso, soy sauce, sauce, etc.).
또한, 본 발명의 건강기능식품은 정제, 환제, 산제, 과립제, 분말제, 캡슐제, 액제 제형 등으로 제형화된 것일 수도 있다. 이들은 담체, 희석제, 부형제 및 첨가제 중 하나 이상을 더 포함하여 제형화될 수 있다.In addition, the health functional food of the present invention may be formulated into tablets, pills, powders, granules, powders, capsules, liquid formulations, and the like. They may be formulated further comprising one or more of carriers, diluents, excipients and additives.
상기 담체, 부형제, 희석제 및 첨가제의 구체적인 예로는 이에 한정하는 것은 아니나, 락토즈, 덱스트로즈, 슈크로즈, 솔비톨, 만니톨, 에리스리톨, 전분, 아카시아 고무, 인산칼슘, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 미세결정성 셀룰로즈, 폴리비닐피롤리돈, 셀룰로즈, 폴리비닐피롤리돈, 메틸셀룰로즈, 물, 설탕시럽, 메틸셀룰로즈, 메틸 하이드록시 벤조에이트, 프로필하이드록시 벤조에이트, 활석, 스테아트산 마그네슘 및 미네랄 오일로 이루어진 그룹으로부터 선택된 1종 이상이 사용되는 것이 바람직하다.Specific examples of the carrier, excipient, diluent and additive are, but are not limited to, lactose, dextrose, sucrose, sorbitol, mannitol, erythritol, starch, gum acacia, calcium phosphate, alginate, gelatin, calcium phosphate, calcium Silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, polyvinylpyrrolidone, methylcellulose, water, sugar syrup, methylcellulose, methyl hydroxy benzoate, propyl hydroxy benzoate, talc, magnesium stearate And it is preferable that at least one selected from the group consisting of mineral oil is used.
본 발명의 또 다른 양태로 감귤류 과피 추출물을 포함하는 항산화용 화장료 조성물을 제공한다.Another aspect of the present invention provides an antioxidant cosmetic composition comprising a citrus fruit extract.
본 발명에서 감귤류 과피 추출물에 대한 설명은 전술한 바와 같다.The description of the citrus peel extract in the present invention is as described above.
상기 항산화용 화장료 조성물은 안정화제, 기용화제, 비타민, 안료 및 향료등과 같은 통상적인 보조제 및 담체를 더 포함할 수 있다. The antioxidant cosmetic composition may further include conventional adjuvants and carriers such as stabilizers, solubilizers, vitamins, pigments, and fragrances.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 영양 크림, 수렴 화장수, 유연 화장수, 로션, 에센스, 영양젤 또는 마사지 크림의 제형으로 제조될 수 있다.The cosmetic composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing , Oil, powder foundation, emulsion foundation, wax foundation, and may be formulated as a spray, but is not limited thereto. In more detail, it may be prepared in the form of a nourishing cream, astringent lotion, a flexible lotion, lotion, essence, nourishing gel or massage cream.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide are used as carrier components. Can be.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, toss, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohydrocarbon, propane / May contain propellants such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 가용화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라가칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, and crystallites Sex cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, and the like can be used.
본 발명의 제조방법에 의해 제조된 감귤과피 추출물은 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 및/또는 시넨세틴(Sinensetin)의 플라보노이드 함량이 증가되고, 2,3-디하이드로-3,5-디하이드록시-6-메틸-4(H)-피란-4-온(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP)의 함량 또는/및 5-하이드록시메틸푸르루랄(5-(Hydroxymethyl)furfural, 5-HMF)의 함량이 증가하며, 항산화 효과 등의 생리활성 효과가 우수하여 식품 소재 및 화장품 소재의 개발 등의 다양한 산업분야에 활용될 수 있다. Citrus peel extract prepared by the production method of the present invention increases the flavonoid content of Narirutin, Hesperidin, Nobiletin, Tangeretin and/or Sinensetin, 2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one (2,3-dihydro-3,5-dihydroxy-6-methyl-4(H) The content of -pyran-4-one, DDMP) or/and the content of 5-hydroxymethylfurfural (5-(Hydroxymethyl)furfural, 5-HMF) is increased, and the physiological activity such as antioxidant effect is excellent. It can be used in various industrial fields such as the development of materials and cosmetic materials.
도 1은 덖음 온도별 감귤과피 추출물의 총 폴리페놀 함량 변화를 분석한 결과이다.
도 2는 감귤과피의 덖음 처리에 따른 플라보노이드 5종의 함량(hesperidin, Narirutin, Nobiletin, Tangeretin, Sinensetin) 변화를 분석한 결과이다.
도 3은 감귤과피의 덖음 처리에 따른 추출물의 HPLC 크로마포그래피의 2D contour plot을 나타낸 것이다.
도 4는 감귤과피의 덖음 온도에 따른 2,3-디하이드로-3,5-디하이드록시-6-메틸-4(H)-피란-4-온(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP)와 5-하이드록시메틸푸르루랄(5-(Hydroxymethyl)furfural, 5-HMF)의 함량 변화를 분석한 결과이다.1 is a result of analyzing the change in the total polyphenol content of the citrus peel extract according to the roasting temperature.
FIG. 2 is a result of analyzing changes in the contents of five flavonoids (hesperidin, Narirutin, Nobiletin, Tangeretin, and Sinensetin) according to the roasting treatment of citrus peel.
3 shows a 2D contour plot of HPLC chromatography of an extract according to the abrasion treatment of citrus peel.
4 shows 2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one (2,3-dihydro-3,5-) according to the roasting temperature of citrus peel. This is the result of analyzing the changes in the content of dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP) and 5-hydroxymethylfurfural (5-(Hydroxymethyl)furfural, 5-HMF).
이하, 실시예를 통하여 본 발명의 구성 및 효과를 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 한정되는 것은 아니다.Hereinafter, the configuration and effects of the present invention will be described in more detail through examples. These examples are for illustrative purposes only, and the scope of the present invention is not limited by these examples.
실험방법Experiment method
<실시예1> 시료의 준비<Example 1> Preparation of sample
① 덖음처리① Dry sound treatment
덖음기 가열온도를 250℃로 설정하고 회전속도는 90 rpm으로 감귤(Citurs unshiu) 과피에 전달되는 온도(덖음 온도)가 100 내지 160℃에 도달되도록 온도를 설정하여 28분간 덖음 처리를 수행하였다(표 1).The roasting was performed for 28 minutes by setting the heating temperature of the roaster to 250°C and the rotation speed of 90 rpm so that the temperature delivered to the peel of the citrus (Citrus unshiu) reached 100 to 160°C ( Table 1).
160℃에서 덖은 비교예4의 경우 시료가 타는 문제가 발생하여 이후 실험에서는 비교예4는 제외하고 분석을 수행하였다.In the case of Comparative Example 4, which was heated at 160°C, a problem of burning of the sample occurred, and analysis was performed except for Comparative Example 4 in the subsequent experiment.
② 시료추출② Sample extraction
각 온도별로 덖음 처리한 감귤과피에 10 배 중량의 증류수를 첨가하고 100℃에서 1시간 동안 추출하였다. 각 추출용액은 여과지로 여과한 후, 감압회전농축기를 사용하여 60℃ 에서 농축하여 농축액을 제조하였다. 10 times the weight of distilled water was added to the roasted citrus peels at each temperature, followed by extraction at 100° C. for 1 hour. Each extraction solution was filtered through a filter paper and then concentrated at 60°C using a vacuum rotary concentrator to prepare a concentrated solution.
상기 농축액은 -70℃에서 냉동시킨 후, 동결건조기를 사용하여 오븐온도를 40℃로 설정하고 -80℃로 냉각농도를 설정하여 동결 건조하였다. The concentrate was frozen at -70°C, and then freeze-dried by setting the oven temperature to 40°C using a freeze dryer, and setting the cooling concentration to -80°C.
③ 시료의 제조③ Preparation of sample
동결 건조한 추출물에 DMSO와 에탄올(1:1)의 혼합용매를 첨가하여 100 mg/㎖의 농도로 시료를 제조하였다. A sample was prepared at a concentration of 100 mg/ml by adding a mixed solvent of DMSO and ethanol (1:1) to the freeze-dried extract.
<실시예2> 활성 분석<Example 2> Activity assay
감귤과피의 덖음 온도에 따른 추출물의 항산화 활성 변화를 확인하고자, ABTS 라디칼 소거활성, DPPH 라디칼 소거활성, NO 소거 활성, 크산틴 산화효소(Xanthine oxidase) 저해 활성 및 NO 생성 저해활성을 분석하였다. To confirm the change of antioxidant activity of the extract according to the roasting temperature of citrus peel, ABTS radical scavenging activity, DPPH radical scavenging activity, NO scavenging activity, Xanthine oxidase inhibitory activity and NO production inhibitory activity were analyzed.
① ABTS 라디칼 소거활성 분석① ABTS radical scavenging activity analysis
먼저, 7 mM ABTS와 2.45 mM 과산화황산암모늄(ammonium persulfate)를 동량 혼합하여 ABTS 용액을 제조하고, 24시간 동안 라디칼(radical)이 생성되도록 한 후 사용하였다. First, an ABTS solution was prepared by mixing equal amounts of 7 mM ABTS and 2.45 mM ammonium persulfate, and then used after allowing radicals to be generated for 24 hours.
에탄올에 다양한 농도로 희석시킨 시료를 96 웰 플레이트에 100 ㎕씩 분주하고 상기 ABTS 용액을 동량 첨가하였다. 어두운 곳에서 10분간 반응시킨 후 745 nm 파장으로 흡광도를 측정하여 ABTS 라디칼 소거활성을 분석하였다.Samples diluted in ethanol at various concentrations were dispensed into a 96-well plate by 100 μl, and the ABTS solution was added in the same amount. After reacting in the dark for 10 minutes, absorbance was measured at a wavelength of 745 nm to analyze ABTS radical scavenging activity.
② DPPH 라디칼 소거활성 분석② DPPH radical scavenging activity analysis
먼저 메탄올로 다양한 농도로 희석시킨 시료를 96 웰 플레이트에 100 ㎕씩 분주하고 0.4 mM DPPH 용액 100 ㎕ 첨가하였다. 그 후 어두운 곳에서 10분간 반응시킨 후 517 nm 파장에서 흡광도를 측정하여 DPPH 라디칼 소거활성을 분석하였다.First, 100 µl of a sample diluted with methanol to various concentrations was dispensed into a 96-well plate, and 100 µl of a 0.4 mM DPPH solution was added. Then, after reacting in the dark for 10 minutes, absorbance was measured at a wavelength of 517 nm to analyze DPPH radical scavenging activity.
③ NO 소거 활성 분석 ③ Analysis of NO scavenging activity
5%(v/v) 인산(phosphoric acid)에 용해된 1%(w/v) 설파닐아마이드(sulfanilamide)와 증류수에 용해된 0.1%(w/v) 나프틸에틸렌디아민이염산염(naphthylethylenediamine dihydrochloride)를 혼합하여 그리스 시약(Griess reagent)을 제조하였다.1% (w/v) sulfanilamide dissolved in 5% (v/v) phosphoric acid and 0.1% (w/v) naphthylethylenediamine dihydrochloride dissolved in distilled water The mixture was mixed to prepare a grease reagent.
PBS로 희석시킨 여러 가지 농도의 시료를 96 웰 플레이트에 50㎕씩 분주하고 10mM 니트로프루싯나트륨(sodium nitro-prusside, SNP) 용액을 50㎕씩 첨가하여 실온에서 30분간 반응시켰다. 반응이 끝난 후 그리스 시약(Griess reagent) 100 ㎕을 첨가하여 10분 동안 반응시킨 후 545nm 파장에서 흡광도를 측정하여 NO 소거 활성을 분석하였다. Samples of various concentrations diluted with PBS were dispensed into a 96-well plate by 50 µl, and 50 µl of 10 mM sodium nitro-prusside (SNP) solution was added at a time to react at room temperature for 30 minutes. After the reaction was completed, 100 µl of a Grease reagent was added and reacted for 10 minutes, and then absorbance was measured at a wavelength of 545 nm to analyze NO scavenging activity.
④ 크산틴 산화효소(Xanthine oxidase) 저해 활성 분석 ④ Analysis of xanthine oxidase inhibitory activity
덖음 처리 온도에 따른 크산틴 산화효소 저해 활성을 분석하고자, 슈퍼산화효소(Superoxidase) 라디칼 소거능 및 크산틴 산화효소(Xanthine oxidase) 억제 활성을 분석하였다.In order to analyze the xanthine oxidase inhibitory activity according to the abrasion treatment temperature, superoxidase radical scavenging activity and xanthine oxidase inhibitory activity were analyzed.
○ 크산틴 산화효소 슈퍼옥사이드 소거능 활성 분석○ Analysis of xanthine oxidase superoxide scavenging activity
다양한 농도의 시료와 1 mM 크산틴(xanthine)과 2 mM EDTA(pH7.5)와 0.3 mM 니트로블루 테트라졸륨(nitroblue tetrazolium, NBT)를 함유한 200 mM sodium phosphate buffer(pH 7.5) 100 ㎕에 50 mU/㎖ 크산틴 산화효소(xanthine oxidase)를 첨가하여 15분 동안 반응시킨 후 550 nm 파장에서 흡광도를 측정하여 크산틴 산화효소 수퍼옥사이드 라디칼 소거 활성을 분석하였다.In 100 µl of 200 mM sodium phosphate buffer (pH 7.5) containing 1 mM xanthine, 2 mM EDTA (pH7.5) and 0.3 mM nitroblue tetrazolium (NBT) at various concentrations, 50 After adding mU/ml xanthine oxidase and reacting for 15 minutes, absorbance was measured at 550 nm wavelength to analyze xanthine oxidase superoxide radical scavenging activity.
○ 크산틴 산화효소(Xanthine oxidase) 저해 활성○ Xanthine oxidase inhibitory activity
Xanthine oxidase 억제 활성은 다양한 농도의 시료와 1mM xanthine과 2 mM EDTA를 함유한 200 mM 인산나트륨 버퍼(sodium phosphate buffer, pH 7.5) 100 ㎕에 50 mU/㎖ xanthine oxidase를 첨가하여 요산(uric acid)의 생성을 유도하였고 290 nm 파장에서 흡광도를 측정하여 크산틴 산화효소(Xanthine oxidase) 저해 활성을 분석하였다. Xanthine oxidase inhibitory activity was determined by adding 50 mU/ml xanthine oxidase to 100 μl of 200 mM sodium phosphate buffer (pH 7.5) containing various concentrations of samples and 1 mM xanthine and 2 mM EDTA. Production was induced, and absorbance was measured at a wavelength of 290 nm to analyze xanthine oxidase inhibitory activity.
⑤ NO 생성 저해 활성 분석 ⑤ Analysis of NO production inhibitory activity
RAW 264.7 세포를 96 웰 플레이트에 최종 농도가 1.5×105 세포/㎖가 되도록 분주하고, 10% FBS가 포함된 DMEM (Dulbecco`s modified Eagle`s medium) 배지에서 24시간 배양하였다. 그 후 10% FBS가 포함된 배지에 각 시료를 처리하고 1시간 후 LPS(200 ng/㎖)를 처리하여 24시간 배양하고, 상층액을 회수하였다. RAW 264.7 cells were dispensed into a 96-well plate to a final concentration of 1.5×10 5 cells/ml, and cultured in DMEM (Dulbecco’s modified Eagle’s medium) medium containing 10% FBS for 24 hours. Then, each sample was treated in a medium containing 10% FBS, and after 1 hour, LPS (200 ng/ml) was treated and cultured for 24 hours, and the supernatant was recovered.
상기 상층액 100㎖에 Griess 시약 100 ㎖를 혼합하여 10분 동안 반응시킨 후 540 nm에서 흡광도를 측정하여 NO 생성 저해 활성을 분석하였다. 100 ml of the Griess reagent was mixed with 100 ml of the supernatant and reacted for 10 minutes, and the absorbance was measured at 540 nm to analyze the NO production inhibitory activity.
<실시예3> 덖음 온도에 따른 감귤과피의 성분 변화 분석<Example 3> Analysis of Changes in Components of Citrus Peel According to Roasting Temperature
① 총 폴리페놀 함량 분석① Total polyphenol content analysis
총 폴리페놀 함량은 시료용액 0.5㎖에 증류수 1.0㎖와 2N Follin-Ciocalteau’s phenol reagent 0.5㎖를 가하여 실온에서 5분간 반응시켰다. 여기에 7% Na2CO3 용액 2.0㎖를 가하여 혼합하고 실온에서 90분간 반응시킨 후 750nm에서 흡광도를 측정하였다. 표준물질은 갈산(gallic acid)를 이용하여 농도별 표준곡선을 작성한 후 총 폴리페놀 함량을 구하였다.For the total polyphenol content, 1.0 ml of distilled water and 0.5 ml of 2N Follin-Ciocalteau's phenol reagent were added to 0.5 ml of the sample solution, and reacted at room temperature for 5 minutes. 2.0 ml of a 7% Na 2 CO 3 solution was added thereto, mixed, reacted at room temperature for 90 minutes, and absorbance was measured at 750 nm. As a standard substance, a standard curve for each concentration was drawn up using gallic acid, and the total polyphenol content was calculated.
② 플라보노이드(flavonoid) 성분 분석② Flavonoid component analysis
HPLC를 이용하여 덖음온도에 따른 감귤과피의 플라보노이드 함량 변화를 분석하였다. 아래와 같이 표준 용액과 시험용액을 제조하고 표 2의 조건으로 HPLC를 수행하였다. The change of flavonoid content in citrus peels according to the roasting temperature was analyzed using HPLC. A standard solution and a test solution were prepared as follows, and HPLC was performed under the conditions of Table 2.
○ 표준용액 제조○ Preparation of standard solution
표준시약으로 2종의 환원당 생성화합물과 13종의 플라보노이드를 이용하였다.Two reducing sugar compounds and 13 flavonoids were used as standard reagents.
환원당 생성화합물은 5-HMF(5-hydroxymethylfurfural), DDMP((2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one)을 이용하였다. As a reducing sugar-producing compound, 5-HMF (5-hydroxymethylfurfural) and DDMP ((2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one) were used.
플라보노이드는 루틴(Rutin), 에리오시트린(Eriocitrin), 네오에리오시트린(Neoeriocitrin), 나리루틴(Narirutin), 로이폴린(Rhoifolin), 나린진(Naringin), 헤스페리딘(Hesperidin), 네오헤스페리딘(Neohesperidin), 네오폰시린(Neoponcirin), 폰시린(Poncirin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin), 시넨세틴(Sinensetin)을 사용하였다. Flavonoids include Rutin, Eriocitrin, Neoeriocitrin, Narirutin, Rhoifolin, Naringin, Hesperidin, Neohesperidin, and Neohesperidin. Neoponcirin, Poncirin, Nobiletin, Tangeretin, and Sinensetin were used.
표준시약은 메탄올과 DMSO(1/1, v/v) 혼합 용매를 사용하여 100 mg/㎖ stock solution을 제조하였고 이를 희석하여 0.25, 0.5, 1.0 및 5.0 mg/㎖ 표준용액을 제조하였다.The standard reagent was prepared with a mixed solvent of methanol and DMSO (1/1, v/v) to prepare 100 mg/ml stock solution and diluted to prepare 0.25, 0.5, 1.0 and 5.0 mg/ml standard solutions.
○ 시험용액 제조○ Preparation of test solution
감귤과피 덖음 추출물 2 g에 추출용매(DMSO : MeOH = 1:1) 20 ㎖을 첨가하고 10분 동안 초음파(sonication) 처리하여 추출하고, 이를 여과하고 여과한 용액을 20㎖ 메스플라스크로 부피를 맞추었다. 상기 정용한 용액을 0.45㎛ 시린지 필터(syringe filter)로 여과하여 시험용액으로 사용하였다.Add 20 ml of the extraction solvent (DMSO: MeOH = 1:1) to 2 g of citrus peel extract and extract by sonication for 10 minutes, filter this and adjust the volume of the filtered solution with a 20 ml volumetric flask. I got it. The prepared solution was filtered through a 0.45 μm syringe filter and used as a test solution.
(Mobile phase)Mobile phase
(Mobile phase)
B 용매: 3차 증류수
A solvent: methanol (Fisher, HPLC grade)
B solvent: tertiary distilled water
실험결과Experiment result
<실험예1> 덖음 온도에 따른 추출효율<Experimental Example 1> Extraction efficiency according to the roasting temperature
덖음 온도가 상승할수록 감귤과피의 추출효율도 증가하는 것을 확인하였으며, 155℃일 때 추출효율이 덖음 처리를 하지 않은 비교예1보다 8.6% 더 높게 나타나 추출효율이 가장 우수함을 확인하였다(표 3). It was confirmed that the extraction efficiency of citrus peels increased as the roasting temperature increased.At 155℃, the extraction efficiency was 8.6% higher than that of Comparative Example 1 without the roasting treatment, confirming that the extraction efficiency was the best (Table 3). .
(℃)Abrasion temperature
(℃)
(비교예1)No treatment
(Comparative Example 1)
(비교예2)100
(Comparative Example 2)
(비교예3)120
(Comparative Example 3)
(실시예1)140
(Example 1)
(실시예2)145
(Example 2)
(실시예3)150
(Example 3)
(실시예4)155
(Example 4)
(g)Sample weight
(g)
(g)Extraction weight
(g)
(%)Extraction efficiency
(%)
<실험예2> 덖음 온도에 따른 활성 변화<Experimental Example 2> Activity change according to the roasting temperature
감귤과피는 무처리 시료와 비교하여 덖음 처리한 시료에서 항산화 활성이 증가하는 경향을 보였으며, 덖음 온도가 증가함에 따라 항산화 활성이 증가하였다. 구체적으로, 155℃에서 덖음 처리한 실시예4가 DPPH 또는 ABTS 라디칼 소거활성이 우수하여 항산화 효과가 우수함을 확인하였다.Citrus peels showed a tendency to increase the antioxidant activity in the roasted samples compared to the untreated samples, and the antioxidant activity increased as the roasting temperature increased. Specifically, it was confirmed that Example 4, which was subjected to abrasion treatment at 155°C, was excellent in DPPH or ABTS radical scavenging activity, so that the antioxidant effect was excellent.
또한, 155℃에서 덖음 처리한 실시예4가 수퍼옥사이드(super oixide) 및 uric acid(요산)의 생성 저해 효과가 우수함을 확인하였다. In addition, it was confirmed that Example 4, which was subjected to abrasion treatment at 155°C, had an excellent inhibitory effect on the production of super oxide and uric acid.
구체적으로 실시예4가 통풍치료제인 알로푸리놀(allopurinol, ALLO)보다 요산 생성 억제 효과가 우수함을 확인하였으며, 항산화제인 부틸레이티드하이드록시아니솔(Butylated hydroxyanisol, BHA)와 비교하여 수퍼옥사이드 소거 활성이 우수함을 확인하였는바, 크산틴 산화효소 저해가 우수함을 확인하였다. Specifically, it was confirmed that Example 4 has superior uric acid production inhibitory effect than allopurinol (ALLO), which is a gout treatment, and superoxide scavenging activity compared to butylated hydroxyanisol (BHA), an antioxidant. As a result of confirming this excellence, it was confirmed that the inhibition of xanthine oxidase was excellent.
크산틴 산화 효소 저해는 혈중 또는 뇨중의 요산 생성을 억제하여 요산 축적으로 인해 발생하는 고요산혈증 또는 통풍의 예방 또는 개선용도로 이용할 수 있다. Xanthine oxidase inhibition can be used for preventing or improving hyperuricemia or gout caused by uric acid accumulation by inhibiting the production of uric acid in blood or urine.
따라서 덖음 처리한 감귤 과피 추출물은 크산틴 산화효소의 저해를 통해 혈중 또는 뇨중의 요산을 감소시켜 고요산 혈증 또는 통풍의 개선 또는 예방에 활용할 수 있다. Therefore, the astringent-treated citrus peel extract can be used to improve or prevent hyperuricemia or gout by reducing uric acid in blood or urine through inhibition of xanthine oxidase.
<< 실험예3Experimental Example 3 > > 덖음Thinness 온도에 따른 Temperature dependent 총페놀Total phenol 함량 변화 Content change
도 1는 덖음 온도에 따른 총 폴리페놀 함량(Total polyphenolics contents, TPC)을 분석한 결과이다. 도 1에서 덖음 온도가 높을수록 총 폴리페놀 함량이 높음을 확인하였다. 구체적으로 100 내지 120℃에서는 281.5 내지 288.18mg/g로 비교예1과 비교하여 27.9 내지 31.5mg/g 증가하였으며, 140℃ 내지 155℃에서 367.9 내지 488.8mg/g로 비교예1과 비교하여 총 폴리페놀 함량이 111.3 내지 192.2 mg/g이 증가하는 것을 확인하였다. 1 is a result of analyzing total polyphenolics contents (TPC) according to the roasting temperature. In Figure 1, it was confirmed that the higher the roasting temperature, the higher the total polyphenol content. Specifically, at 100 to 120 ℃ 281.5 to 288.18mg / g increased 27.9 to 31.5mg / g compared to Comparative Example 1, and at 140 ℃ to 155 ℃ 367.9 to 488.8mg / g compared to Comparative Example 1 Total poly It was confirmed that the phenol content increased from 111.3 to 192.2 mg/g.
즉, 덖음온도 100 내지 120℃에서는 총 폴리페놀 함량이 무처리군의 10.9% 내지 12.3% 증가하였고, 덖음 온도 140℃ 이상에서 무처리 시료와 비교하여 총 폴리페놀함량이 43.4% 이상 증가하였다. 따라서 140℃ 이상에서 덖음 처리하는 것이 총 폴리페놀 함량 증가에 효과적임을 확인하였고, 155℃에서 덖은 시료의 총 폴리페놀 함량이 무처리 대조군과 비교하여 74.9% 증가하여 폴리페놀의 함량 증가가 가장 우수함을 확인하였는바, 155℃가 폴리페놀을 증가시키는 우수한 덖음 온도 조건임을 확인하였다. That is, the total polyphenol content increased by 10.9% to 12.3% of the untreated group at a roasting temperature of 100 to 120°C, and the total polyphenol content increased by 43.4% or more compared to the untreated sample at a roasting temperature of 140°C or higher. Therefore, it was confirmed that roasting treatment at 140°C or higher was effective in increasing the total polyphenol content, and the total polyphenol content of the roasted sample at 155°C increased 74.9% compared to the untreated control group, resulting in the greatest increase in polyphenol content. As a result, it was confirmed that 155°C was an excellent temperature condition for increasing polyphenols.
또한, 160℃에서 덖음 처리를 하는 경우, 감귤과피가 타서 실험을 수행할 수 없었다. In addition, when the abrasion treatment was performed at 160° C., citrus peels burned and the experiment could not be performed.
<실험예4> 플라보노이드 주요성분 함량 변화<Experimental Example 4> Changes in the content of major components of flavonoids
감귤과피 내 존재한다고 보고된 13종의 플라보노이드(flavonoid)에 대한 함량분석을 실시하였다. Content analysis of 13 flavonoids reported to be present in citrus peel was conducted.
구체적으로 루틴(Rutin), 에리오시트린(Eriocitrin), 네오에리오시트린(Neoeriocitrin), 나리루틴(Narirutin), 로이폴린(Rhoifolin), 나린진(Naringin), 헤스페리딘(Hesperidin), 네오헤스페리딘(Neohesperidin), 네오폰시린(Neoponcirin), 폰시린(Poncirin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin), 시넨세틴(Sinensetin)의 13종의 플라보노이드에 대해 분석하였으나, 본 실험에서는 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin), 시넨세틴(Sinensetin)의 5종의 플라보노이드만이 검출되었다. Specifically, Rutin, Eriocitrin, Neoeriocitrin, Narirutin, Rhoifolin, Naringin, Hesperidin, Neohesperidin, 13 kinds of flavonoids such as Neoponcirin, Poncirin, Nobiletin, Tangeretin, and Sinensetin were analyzed, but in this experiment Narirutin, Hesperidin (hesperidin), Nobiletin (Nobiletin), Tangeretin (Tangeretin), sinensetin (Sinensetin) only five kinds of flavonoids were detected.
또한, 덖음처리 온도가 상승할수록 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin), 시넨세틴(Sinensetin)의 flavonoid 함량이 각각 증가되는 것으로 확인하였다(도 2). In addition, it was confirmed that the flavonoid content of Narirutin, Hesperidin, Nobiletin, Tangeretin, and Sinensetin increased as the abrasion treatment temperature increased (Fig. 2). .
감귤과피에 가장 많이 포함된 나리루틴(Narirutin)은 덖음 처리 전 12.43mg/g에서 155℃로 덖음 후 15.32mg/g으로 2.89 mg/g 함량이 증가하였다. 즉 155℃에서 덖은 시료가 무처리 시료보다 narirutin의 함량이 약 23%의 증가하였다.The content of Narirutin, which is most frequently contained in citrus peels, increased from 12.43mg/g before roasting to 155℃ after roasting to 15.32mg/g, increasing to 2.89 mg/g. In other words, the content of narirutin increased by about 23% in the sample roasted at 155°C compared to the untreated sample.
감귤류에 가장 넓은 범위에서 발견되는 플라보노이드인 헤스페리딘(hesperidin)은 덖음 처리 전 8.16mg/g에서 155℃로 덖음 후 11.50 mg/g으로 3.34 mg/g 함량이 증가하였다. 즉 155℃에서 덖은 시료가 무처리 시료보다 hesperidin의 함량이 약 41%의 증가하였다. Hesperidin, a flavonoid found in the widest range of citrus fruits, increased by 3.34 mg/g from 8.16 mg/g before roasting to 11.50 mg/g after roasting at 155°C. That is, the hesperidin content increased by about 41% in the sample roasted at 155°C compared to the untreated sample.
그리고 세 개의 폴리메톡시플라보노이드(polymethoxyflavonoid) 성분 함량도 덖음 처리 시 증가하는 것을 확인하였다. 구체적으로 노빌레틴(Nobiletin)은 무처리 시료에서 0.31mg/g으로 측정되었으며, 100 내지 120℃로 처리한 시료에서는 0.30 내지 0.31mg/g 로 측정되어 함량변화가 거의 없음을 확인하였으며, 140℃ 이상에서 덖음 처리시 0.33 내지 0.39mg/g으로 함량이 증가하였다. 구체적으로 155℃로 덖음 처리한 시료는 노빌레틴(Nobiletin)의 함량이 0.39mg/g으로 무처리 군과 비교하여 약 26% 증가하였다. In addition, it was confirmed that the content of the three polymethoxyflavonoid components also increased during the abrasion treatment. Specifically, nobiletin was measured as 0.31mg/g in the untreated sample, and it was measured as 0.30 to 0.31mg/g in the sample treated at 100 to 120°C, confirming that there was little change in content, and more than 140°C. The content increased from 0.33 to 0.39mg/g during the abrasion treatment at. Specifically, the abrasion-treated sample at 155°C had a nobiletin content of 0.39 mg/g, which was increased by about 26% compared to the untreated group.
탄게레틴(Tangeretin)의 함량은 무처리 시료에서 0.09mg/g으로 측정되었으며, 100 내지 120℃에서 0.09 내지 0.10mg/g로 측정되었고, 140 내지 155℃ 처리한 시료에서 0.10 내지 0.12mg/g로 증가하였고, 155℃에서 0.12mg/g으로 가장 함량이 높음을 확인하였다. The content of Tangeretin was measured as 0.09mg/g in the untreated sample, 0.09 to 0.10mg/g at 100 to 120°C, and 0.10 to 0.12mg/g in the sample treated at 140 to 155°C. It was increased, and it was confirmed that the content was the highest at 155°C, 0.12mg/g.
시넨세틴(Sinensetin) 함량은 무처리 시료와 100℃, 120℃에서 덖은 시료에서는 0.07mg/g으로 측정되었으나, 140℃에서 0.09 mg/g, 145 내지 150℃에서 0.13mg/g, 155℃에서 0.15mg/g으로 증가하여 140℃ 이상에서 함량이 증가하였으며, 155℃에서 함량이 가장 가자 높음을 확인하였다. Sinensetin content was measured to be 0.07 mg/g in the untreated sample and in the sample roasted at 100°C and 120°C, but 0.09 mg/g at 140°C, 0.13 mg/g at 145 to 150°C, and at 155°C. It was confirmed that the content increased to 0.15mg/g and increased at 140℃ or higher, and the content was the highest at 155℃.
즉, 140℃ 내지 155℃로 덖음 처리한 감귤과피 추출물에서 플라보노이드(flavonoid) 함량이 크게 증가하는 것을 확인하였다. 구체적으로, 140℃ 내지 155℃로 덖음 처리한 감귤과피 추출물에서 플라보노이드인 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin) 및 시넨세틴(Sinensetin)이 함량이 증가하였으며, 155℃에서 덖음 처리한 감귤과피 추출물에서 나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin) 및 시넨세틴(Sinensetin)이 함량이 가장 높음을 확인하였다.That is, it was confirmed that the flavonoid content was significantly increased in the citrus peel extract treated at 140°C to 155°C. Specifically, the content of flavonoids Narirutin, hesperidin, nobiletin, and sinensetin was increased in the citrus peel extract treated at 140°C to 155°C. It was confirmed that the contents of Narirutin, Hesperidin, Nobiletin, and Sinensetin were the highest in the treated citrus peel extract.
<실험예5> 덖음 처리에 의한 신규 화합물의 생성<Experimental Example 5> Generation of a new compound by abrasion treatment
다음으로 도 3의 HPLC 크로마토그래피의 2D contour plot에서 덖음 처리(155℃)에 의해 2종의 화합물이 생성되는 것을 확인하였다. 상기 2종의 화합물을 prep-LC를 이용하여 분리하였고 분석하였다. 분석결과, 상기 화합물은 2,3-디하이드로-3,5-디하이드록시-6-메틸-4(H)-피란-4-온(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP)와 5-히드록시메탈푸르푸랄(5-(Hydroxymethyl)furfural, 5-HMF)임을 확인하였다. Next, it was confirmed that two kinds of compounds were generated by the abrasion treatment (155°C) in the 2D contour plot of the HPLC chromatography of FIG. 3. The two compounds were separated and analyzed using prep-LC. As a result of the analysis, the compound was 2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one (2,3-dihydro-3,5-dihydroxy-6- It was confirmed that they were methyl-4(H)-pyran-4-one, DDMP) and 5-hydroxymetalfurfural (5-(Hydroxymethyl)furfural, 5-HMF).
도 4에서 덖음 온도에 따른 DDMP와 5-HMF의 함량을 분석한 결과, DDMP는 무처리 온도에서 약 0.20mg/g이 검출되었고, 140℃에서 9.83mg/g이 생성되어 155℃일 때 19.17mg/g으로 가장 높은 함량을 나타내었다. 120℃에서 1.83mg/g으로 DDMP의 함량이 무처리 온도시료보다 증가하였으나, 140℃에서 150℃사이 조건과 비교시 매우 낮은 함량을 나타내었다. 5-HMF인 경우 무처리 시료 및 100℃에서 덖은 감귤에서는 검출되지 않았으나, 120℃ 에서 5 HMF 가 0.16mg/g 생성되었으며, 140℃ 내지 155℃에서 2.98 내지 16.77mg/g로 생성되어 덖음 온도가 증가함에 따라 5-HMF 의 함량이 증가함을 확인하였다. 또한, 155℃에서 16.77mg/g로 함량이 가장 높음을 확인하였다. As a result of analyzing the content of DDMP and 5-HMF according to the roasting temperature in FIG. 4, about 0.20 mg/g of DDMP was detected at the untreated temperature, and 9.83 mg/g was produced at 140° C. and 19.17 mg at 155° C. The highest content was shown in /g. The content of DDMP was increased from 120°C to 1.83mg/g compared to the untreated temperature sample, but showed a very low content compared to the conditions between 140°C and 150°C. In the case of 5-HMF, it was not detected in untreated samples and citrus roasted at 100°C, but 0.16mg/g of 5 HMF was produced at 120°C, and 2.98 to 16.77mg/g at 140°C to 155°C, resulting in the roasting temperature. It was confirmed that the content of 5-HMF increased as was increased. In addition, it was confirmed that the content was the highest at 16.77mg/g at 155°C.
Claims (7)
나리루틴(Narirutin), 헤스페리딘(hesperidin), 노빌레틴(Nobiletin), 탄게레틴(Tangeretin) 및 시넨세틴(Sinensetin)로 이루어진 군에서 선택되는 하나 이상의 플라보노이드의 함량, 2,3-디하이드로-3,5-디하이드록시-6-메틸-4(H)-피란-4-온(2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP)의 함량, 항산화 활성 또는 크산틴 산화효소 저해활성이 증가된 감귤류 과피 추출물의 제조방법.Comprising the step of roasting the citrus peel to a temperature of 140 to 155 ℃,
Content of one or more flavonoids selected from the group consisting of Narirutin, Hesperidin, Nobiletin, Tangeretin and Sinensetin, 2,3-dihydro-3,5 -Dihydroxy-6-methyl-4(H)-pyran-4-one (2,3-dihydro-3,5-dihydroxy-6-methyl-4(H)-pyran-4-one, DDMP) A method of preparing a citrus fruit extract with increased content, antioxidant activity, or xanthine oxidase inhibitory activity.
상기 감귤과피 추출물은 동시에 5-하이드록시메틸푸르루랄(5-(Hydroxymethyl)furfural, 5-HMF)의 함량이 증가된 것인,
감귤류 과피 추출물의 제조방법.In claim 1,
The citrus peel extract has an increased content of 5-hydroxymethylfurfural (5-(Hydroxymethyl)furfural, 5-HMF) at the same time,
Method for producing citrus peel extract.
제조방법.In claim 1, the rolling step is performed at a temperature of 155 °C,
Manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210041320A KR20210040899A (en) | 2021-03-30 | 2021-03-30 | Method for preparing Citrus peel extract containing increased content of flavonoid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210041320A KR20210040899A (en) | 2021-03-30 | 2021-03-30 | Method for preparing Citrus peel extract containing increased content of flavonoid |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190123210 Division | 2019-10-04 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210052787A Division KR20210048467A (en) | 2021-04-23 | 2021-04-23 | Method for preparing Citrus peel extract containing increased content of flavonoid |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210040899A true KR20210040899A (en) | 2021-04-14 |
Family
ID=75477804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210041320A KR20210040899A (en) | 2021-03-30 | 2021-03-30 | Method for preparing Citrus peel extract containing increased content of flavonoid |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210040899A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100770746B1 (en) | 2006-06-15 | 2007-10-30 | 제주대학교 산학협력단 | .nobiletin from citrus having anti-inflammation activity and the method of separation and purify |
-
2021
- 2021-03-30 KR KR1020210041320A patent/KR20210040899A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100770746B1 (en) | 2006-06-15 | 2007-10-30 | 제주대학교 산학협력단 | .nobiletin from citrus having anti-inflammation activity and the method of separation and purify |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mäkynen et al. | Cultivar variations in antioxidant and antihyperlipidemic properties of pomelo pulp (Citrus grandis [L.] Osbeck) in Thailand | |
CA2732306C (en) | Muscadine compositions with improved anti-oxidant activity | |
CA2732426C (en) | Method of preparing a muscadine pomace extract | |
CN1528197A (en) | Bamboo leaf antioxide and use thereof | |
Abd Elkader et al. | Phytogenic compounds from avocado (Persea americana L.) extracts; antioxidant activity, amylase inhibitory activity, therapeutic potential of type 2 diabetes | |
JP3510526B2 (en) | Anti-atherosclerotic food | |
KR20210048467A (en) | Method for preparing Citrus peel extract containing increased content of flavonoid | |
Oboh et al. | Inhibitory effect of polyphenolic–rich extract from Cola nitida (Kolanut) seed on key enzyme linked to type 2 diabetes and Fe2+ induced lipid peroxidation in rat pancreas in vitro | |
JP2003342185A (en) | Inhibitor of lipase activity | |
KR20180040534A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
Usha et al. | Pomegranate peel and its anticancer activity: A mechanism-based review | |
Kshitiz et al. | Anti-cariogenic effects of polyphenol plant products-a review | |
KR101322503B1 (en) | Composition for Prevention and Treatment of Obesity Comprising Liriope Seed Extracts | |
JP2010184886A (en) | New compound | |
KR20210040899A (en) | Method for preparing Citrus peel extract containing increased content of flavonoid | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR100314477B1 (en) | Composition for improving lipid metabolism and decreasing bllod pressure which comprises jujube and citrus peel extracts | |
KR101381850B1 (en) | Composition comprising curcuma longa extract having anti-cholesterol activities and the method curcuma longa extract | |
KR20050110186A (en) | Antioxidant containing ferulic acid, caffeic acid, chlorogenic acid or an extract of boravalley potato as an effective ingredient | |
KR100782023B1 (en) | Flavonoid fractions comprising neohesperidin from citrus grandis, that having physiological activity | |
KR100490799B1 (en) | Food comprising an extract of bambusoideae plant or tricin isolated therefrom | |
JP5900896B2 (en) | Blood sugar level rise inhibitor | |
Marnewick | Antioxidant properties of Rooibos (Aspalathus linearis)–in vitro and in vivo evidence | |
KR20170077980A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
WO2019131274A1 (en) | Method for producing fermentation product derived from green tea extract, and koji fermentation product derived from green tea extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
WITB | Written withdrawal of application |